18 January 2024 - NICE has published additional draft guidance on the use of remdesivir and the combination of tixagevimab ...
11 January 2024 - A further 1.4 million people who have an increased risk for progression to severe COVID-19 will be ...
14 June 2023 - NICE has published final evidence-based recommendations on the use of tixagevimab and cilgavimab (Evusheld) for the ...
4 May 2023 - NICE is conducting a partial rapid review of TA878. ...
22 February 2023 - Final draft guidance based on cost effectiveness evaluation of sotrovimab. ...
16 February 2023 - NICE has today issued draft guidance for public consultation which does not recommend Evusheld for preventing COVID-19 ...
16 November 2022 - Three treatments for COVID have been recommended in draft NICE guidance released today for public consultation. ...
15 August 2022 - The UK Government has said that it will not procure the COVID-19 drug Evusheld—a combination of ...
12 August 2022 - Half a million people in the UK with conditions like blood cancer that prevents them being ...
5 May 2022 - The NHS is rolling out a cutting-edge, life-saving COVID treatment from today, which is proven to ...
9 April 2022 - Thousands of patients with COVID-19 who are most likely to be admitted to hospital are receiving ...
21 September 2021 - The UK has secured supply of Ronapreve, a new COVID-19 therapeutic developed by Regeneron and Roche ...
7 April 2021 - The UK rollout of Moderna's coronavirus vaccine has begun today in Wales, following its approval back ...
23 March 2021 - One year on from the first national lockdown, NICE has today published a single guideline for the ...
5 January 2021 - Appleby asks whether COVID-19 vaccines would be considered cost effective using the NICE approach to measuring ...